Company Performance Metrics
ExoGenis develops an injection-free, device-based delivery platform for biologically active compounds used in aesthetic and dermatology workflows. The company focuses on overcoming skin barrier limitations by using a dissolvable microneedle patch interface that targets the viable epidermis for controlled biologic uptake. Its technology is designed
to deliver exosomes, peptides, growth factors, and other fragile biologics beyond the skin surface with consistent depth and dose. ExoGenis integrates into clinical procedures such as laser, radiofrequency, microneedling, and injectables, adding a structured treatment layer immediately post-procedure and between visits. The platform supports clinic-guided maintenance protocols that patients can continue at home under professional guidance. ExoGenis also collaborates with aesthetic manufacturers and pharmaceutical labs to pair its delivery system with different biologic payloads and indications.
